Emerging role of exosomes in cancer progression and tumor microenvironment remodeling

MDA Paskeh, M Entezari, S Mirzaei, A Zabolian… - Journal of hematology & …, 2022 - Springer
Cancer is one of the leading causes of death worldwide, and the factors responsible for its
progression need to be elucidated. Exosomes are structures with an average size of 100 nm …

Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine

D Lopes, J Lopes, M Pereira-Silva, D Peixoto… - Military Medical …, 2023 - Springer
A bio-inspired strategy has recently been developed for camouflaging nanocarriers with
biomembranes, such as natural cell membranes or subcellular structure-derived …

Delivery of functional exogenous proteins by plant-derived vesicles to human cells in vitro

L Garaeva, R Kamyshinsky, Y Kil, E Varfolomeeva… - Scientific reports, 2021 - nature.com
Plant-derived extracellular vesicles (EVs) gain more and more attention as promising
carriers of exogenous bioactive molecules to the human cells. Derived from various edible …

Potential of Plant Exosome Vesicles from Grapefruit (Citrus × paradisi) and Tomato (Solanum lycopersicum) Juices as Functional Ingredients and Targeted Drug …

A Kilasoniya, L Garaeva, T Shtam, A Spitsyna… - Antioxidants, 2023 - mdpi.com
Plant-derived extracellular vesicles (PEVs) have gained attention as promising bioactive
nutraceutical molecules; their presence in common fruit juices has increased their …

Molecular and circulating biomarkers in patients with glioblastoma

N Senhaji, A Squalli Houssaini, S Lamrabet… - International Journal of …, 2022 - mdpi.com
Glioblastoma is the most aggressive malignant tumor of the central nervous system with a
low survival rate. The difficulty of obtaining this tumor material represents a major limitation …

Therapeutic and diagnostic potential of exosomes as drug delivery systems in brain cancer

DI Avgoulas, KS Tasioulis, RM Papi, AA Pantazaki - Pharmaceutics, 2023 - mdpi.com
Cancer is designated as one of the principal causes of mortality universally. Among different
types of cancer, brain cancer remains the most challenging one due to its aggressiveness …

Glioblastoma-derived exosomes as nanopharmaceutics for improved glioma treatment

H Lee, K Bae, AR Baek, EB Kwon, YH Kim, SW Nam… - Pharmaceutics, 2022 - mdpi.com
The use of cancer-derived exosomes has been studied in several cancer types, but the
cancer-targeting efficacy of glioma-derived exosomes has not been investigated in depth for …

Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2–Radiological features and metric markers

C Le Fevre, JM Constans, I Chambrelant… - Critical reviews in …, 2021 - Elsevier
After chemoradiotherapy for glioblastoma, pseudoprogression can occur and must be
distinguished from true progression to correctly manage glioblastoma treatment and follow …

The current landscape of glioblastoma biomarkers in body fluids

S Zanganeh, E Abbasgholinejad, M Doroudian… - Cancers, 2023 - mdpi.com
Simple Summary Glioblastoma is a highly aggressive brain cancer, and early detection and
accurate diagnosis are crucial for effective treatment. Traditional diagnostic methods have …

Effects of glioblastoma-derived extracellular vesicles on the functions of immune cells

OE Musatova, YP Rubtsov - Frontiers in cell and developmental …, 2023 - frontiersin.org
Glioblastoma is the most aggressive variant of glioma, the tumor of glial origin which
accounts for 80% of brain tumors. Glioblastoma is characterized by astoundingly poor …